Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia ; volume:25 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2024
The Egyptian journal of medical human genetics ; 25, Heft 1 (3.12.2024), 1-13, 12.2024
- Urheber
-
Tasneem, Alvea
Sharma, Archana
Syed, Mansoor Ali
Dohare, Ravins
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-024-00614-2
- URN
-
urn:nbn:de:101:1-2502172139599.677999251523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tasneem, Alvea
- Sharma, Archana
- Syed, Mansoor Ali
- Dohare, Ravins
- SpringerLink (Online service)
Ähnliche Objekte (12)
The genomic & transcriptomic landscape of acute myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting
The genomic & transcriptomic landscape of acute myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting
The genomic & transcriptomic landscape of acute myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia